3 hours Zacks Research Weighs in on AbbVie’s Q1 Earnings (NYSE:ABBV)MarketBeat
AbbVie Inc. (NYSE:ABBV – Free Report) – Investment analysts at Zacks Research lowered their Q1 2025 EPS estimates for shares of AbbVie in a research note issued on Thursday, October 17th. Zacks Research analyst S. Ganoria now forecasts that the comp…
AbbVie (ABBV) · Earnings · NYSE · Science
X